Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3UGA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,852
Award facts
- Contract value 100% obligated
- $15,852.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,852.05 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price contract represents a non-set-aside competitive award to the prime contractor, with performance taking place at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the underlying vehicle for this delivery order.
Dupixent (dupilumab) is a biologic medication used to treat multiple conditions including moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and certain asthma conditions. This delivery order supports the military healthcare supply chain by providing this specialty pharmaceutical product to military treatment facilities and associated federal medical programs. The contract award demonstrates Cencora's ongoing role as a critical pharmaceutical distributor for federal agencies, particularly in fulfilling requirements for specialty medications across multiple therapeutic domains that support the Defense Health Agency and broader military medical operations.
Quick answers
Who was awarded contract SPE2DR26F3UGA?
SPE2DR26F3UGA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F3UGA worth?
The government has obligated $15,852 on SPE2DR26F3UGA.
Is contract SPE2DR26F3UGA an order under another contract?
Yes. SPE2DR26F3UGA is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UGA competed?
The extent of competition for SPE2DR26F3UGA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award